Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/12/2010US7812004 For modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine; anticancer agents; dietary fibre effects, improved mineral absorption (calcium and magnesium), for treating osteoporosis
10/12/2010US7812002 A double-stranded small interfering siRNA compound which inhibits the gene expression of Nuclear Respiratory Factor 2 (NRF2); anticarcinogenic agents; non-small cell lung carcinoma or small cell lung carcinoma and others
10/12/2010US7812001 RNA aptamers and methods for identifying the same
10/12/2010US7812000 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
10/12/2010US7811999 Use of lipid conjugates in the treatment of diseases
10/12/2010US7811998 Novobiocin analogues as anticancer agents
10/12/2010US7811997 From bamboo using carbon dioxide Supercritical Fluid Extraction; a mixture comprising friedelin,lupenone and homologues; hypotensive agents; anticarcinogenic agents; antitumor agents; free radical scavengers; oxidation resistance; cardiovascular disorders; sin, hair cosmetics; oral administration
10/12/2010US7811996 Administering stilbene derivatives such as tetramethoxy-stilbene or resveratrol
10/12/2010US7811988 A lipid mixture for synthetic surfactants comprising >40% by weight of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and >10% of polyunsaturated phospholipids; treatment of surfactant deficiencies like infant respiratory distress syndrome (RDS); rheology; low surface tension; fast spreading
10/12/2010US7811822 Modulation of neural stem cells and neural progenitor cells
10/12/2010US7811814 for nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector
10/12/2010US7811813 Methods and immune modulatory nucleic acid compositions for preventing and treating disease
10/12/2010US7811610 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
10/12/2010US7811609 Use of metal compounds to treat gastrointestinal infections
10/12/2010US7811606 Beclomethasone powders has specific particle size distribution; increase bioavailability, prolonged therapeutic effect of the drug substance; aqueous suspension for inhalation; drug delivery method and device; rhinitis treatment
10/12/2010US7811600 Nitric oxide donating medical devices and methods of making same
10/12/2010US7811599 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
10/12/2010US7811597 thermoplastic elastomer such as ethylene/propylene rubber, very low density polyethylene, eucalyptus oil odorant, salicylic acid ester, menthol and camphor; repels animals such as cats, dogs, rats, and crows; cable insulation
10/12/2010US7811595 Prolyl hydroxylase inhibitors and methods of use
10/12/2010US7811593 Pharmaceutical composition with combined active agents and methods for using the same
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811568 Smallpox monoclonal antibody
10/12/2010US7811556 polyoxyethylene glycol-allylmethyldiether-maleic acid sodium salt copolymers with fibroblast growth factors; improved conjugation, crosslinking between polymer and protein; formed via hydrolysis, ammonolysis, aminolysis and alcoholysis of anhydride moieties
10/12/2010US7811555 Tri-branched biologically active copolymer
10/12/2010US7811554 Horse liniment
10/12/2010US7811553 A shaving cartridge comprising a housing, shaving blade(s), a shaving aid holder, and the shaving aid portion of silicone cross-polymer, sodium stearate as a soap base, semi-solid esters, polyoxyethylene, and a polyethylene, polybutene and mineral oil composition
10/12/2010US7811549 Concurrently administering a synergistic mixture of adenosine and dipyridamole by parenteral injection, or intraveinous or intra-arterial bolus to cause coronary vasodilation for cardiac diagnosis
10/12/2010US7810643 package backing with columns and rows to hold tablets marked for days and weeks; glaucoma
10/12/2010CA2558585C Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
10/12/2010CA2533919C Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same
10/12/2010CA2507259C Pharmaceutical composition containing bakuchiol for treating female breast cancer
10/12/2010CA2506944C D-mannose contraceptives
10/12/2010CA2494157C Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2477903C Substituted benzofurans useful as protein kinase b activators
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2470578C Tetrahydroquinoline analogues as muscarinic agonists
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2467261C Novel benzophenone derivatives or salts thereof
10/12/2010CA2459470C Pharmaceutical composition comprising gabapentin or an analogue thereof and an .alpha.-aminoamide and its analgesic use
10/12/2010CA2457050C Prophylactic and therapeutic use of hydroxysteroids
10/12/2010CA2456356C Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2455526C Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2441110C Pharmaceutical compositions for treating arteriosclerosis
10/12/2010CA2439097C Pharmaceutical compositions
10/12/2010CA2438657C Testosterone-containing transdermal therapeutic system and process for its production
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2425420C Administration of resveratrol to treat inflammatory respiratory disorders
10/12/2010CA2419552C Substituted pyrazoles
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2415774C Method for treatment of reactive arthritis or bursitis
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2411960C Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
10/12/2010CA2410556C Konjac mannan and polysaccharide compositions and uses thereof
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/12/2010CA2399161C Method for the preparation of functionalised derivated of .beta.-(1,3)-glucans
10/12/2010CA2397964C Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/12/2010CA2387779C Isoalloxazine derivatives to neutralize biological contaminants
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/12/2010CA2338946C Hepatitis c inhibitor tri-peptides
10/12/2010CA2336542C Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
10/12/2010CA2329751C Substituted porphyrins
10/12/2010CA2313089C Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2229590C Pharmaceutical composition containing inhibitors of interferon- gamma
10/12/2010CA2223062C 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
10/07/2010WO2010115206A2 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna
10/07/2010WO2010115177A1 Dosing regimen for the treatment of alzheimer's disease with sulfonyl fluorides
10/07/2010WO2010115164A1 Topical compositions
10/07/2010WO2010115130A1 Histidine derivatives and their pharmaceutical uses
10/07/2010WO2010115125A2 Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010WO2010115124A2 Compositions of cholinesterase inhibitors
10/07/2010WO2010115078A2 Method of treating cognitive impairment
10/07/2010WO2010115055A1 L-ornithine phenyl acetate and methods of making thereof
10/07/2010WO2010115053A2 Methods of using canonical wnts as enhancers for bone formation by human bone-marrow derived mesenchymal stem cells
10/07/2010WO2010115015A1 Modified-release pharmaceutical drug composition
10/07/2010WO2010114982A2 Lyophilization cakes of proteasome inhibitors
10/07/2010WO2010114978A1 Renin inhibitors
10/07/2010WO2010114971A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
10/07/2010WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
10/07/2010WO2010114957A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
10/07/2010WO2010114943A1 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
10/07/2010WO2010114928A2 Compositions and uses thereof
10/07/2010WO2010114922A1 Methods of treating cancer having an aberrant egfr or kras genotype
10/07/2010WO2010114921A1 Eph receptor ligands and methods of use
10/07/2010WO2010114919A2 Metnase and intnase inhibitors and their use in treating cancer
10/07/2010WO2010114905A1 Peri-fused pyrazolo-pyrimidine compounds
10/07/2010WO2010114904A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
10/07/2010WO2010114902A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
10/07/2010WO2010114898A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
10/07/2010WO2010114896A1 Substituted indolo-pyridinone compounds
10/07/2010WO2010114894A1 Substituted heterocyclic compounds
10/07/2010WO2010114861A1 Method of treating osteoporosis
10/07/2010WO2010114824A1 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
10/07/2010WO2010114822A1 Menthol-melatonin dissolving film
1 ... 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 ... 7860